- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
University Bans Researcher From Industry Talks
23 December 2008 4:35 pm
Emory University has taken the unusual step of banning one of its own, prominent psychiatrist Charles Nemeroff, from collecting industry money at certain speaking engagements. The decision comes after Nemeroff spent months under the uncomfortable spotlight of Senator Charles Grassley (R-IA), who accused him of failing to report at least $1.2 million of the more than $2.4 million he earned by consulting for drugmakers. Nemeroff subsequently stepped down from his post as department chair.
Yesterday, Emory reported the results of its internal investigation into Nemeroff's dealings with GlaxoSmithKline. The Atlanta, Georgia, university found that Glaxo paid him more than $800,000 over 5 years for giving 250 speeches, money he did not report to Emory. Although Emory says Nemeroff's failure to disclose the amounts he received didn't taint his research or patient care, the university imposes these limitations on his activities: Nemeroff will need to "seek review and approval by the dean's office of any and all outside compensated engagements before he accepts them," and he can't seek National Institutes of Health grants for 2 years. When it comes to speaking at continuing medical education events, Nemeroff will be permitted to talk only at those "sponsored by academic institutions or professional societies."
Emory spokesperson Ron Sauder declined to tell ScienceInsider whether the measures were taken to appease Grassley or because Emory doesn't trust Nemeroff to participate in industry-sponsored events. "I really can't interpret that for you," Sauder said, beyond noting that the measures don't apply to other faculty members.
Nemeroff said in the statement that he had misunderstood the disclosure rules and thought he was following them properly.